A Phase I Trial of a Trivalent Vaccine with Escalating Doses of the Immunological Adjuvant OPT-821 Plus Oral ß-Glucan for High-Risk Neuroblastoma
[Protocol 05-075] |
Kushner, Brian |
|
A Phase I Trial of NECTAR: Nelarabine, Etoposide, and Cyclophosphamide in Children with T-Cell Acute Lymphoblastic Leukemia
[Protocol 11-119] |
Trippett, Tanya |
- Leukemia
- Acute Lymphoblastic Leukemia
|
A Phase I/II Clinical Study of Vorinostat Plus Etoposide in Pediatric Patients with Refractory Solid Tumors
[Protocol 10-096] |
Trippett, Tanya |
|
A Phase I/II Study of Brentuximab (SGN-35) in Pediatric Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma or Hodgkin Lymphoma
[Protocol 11-210] |
Trippett, Tanya |
- Lymphoma
- Hodgkin's Disease
- Non-Hodgkin's Lymphoma
|
A Phase I/II Study of the Toxic and Therapeutic Effects of T Cells in the Treatment of Epstein Barr Virus-Associated Lymphoproliferative Disorders
[Protocol 95-024] |
O'Reilly, Richard |
- Blood & Marrow Stem Cell Transplantation
- Blood and Marrow Transplantation
- Leukemia
- Lymphoma
|
A Phase I/II Study of Veliparib (ABT-888) Given with Radiation Therapy and then Given with Temozolomide in Children with Newly Diagnosed Diffuse Pontine Glioma
[Protocol 12-176] |
Gilheeney, Stephen |
|
A Phase I/II Trial of Clofarabine, Melphalan, and Thiotepa Followed by an Allogeneic Stem Cell Transplant for the Treatment of High-Risk and/or Advanced Hematologic Malignancies
[Protocol 06-125] |
Boulad, Farid |
- Blood & Marrow Stem Cell Transplantation
- Sibling and Unrelated Volunteer
- Blood and Marrow Transplantation
- Hematology
- Leukemia
|
A Phase II Study Evaluating the Use of Donated EBV-Immune T Cells to Treat Transplant Recipients with EBV
[Protocol 11-130] |
O'Reilly, Richard |
- Blood and Marrow Transplantation
- Lymphoma
|
A Phase II Study of Bevacizumab, Irinotecan, and Temozolomide for Relapsed or Refractory Neuroblastoma
[Protocol 10-015] |
Modak, Shakeel |
|
A Phase II Study of Brentuximab Vedotin in Relapsed or Refractory CD30-positive Non-Hodgkin Lymphoma
[Protocol 12-035] |
Horwitz, Steven |
|
A Phase II Study of Bulk Versus Fractionated Stem Cell Infusions in Patients with Hematologic Cancers Undergoing Stem Cell Transplantation
[Protocol 12-016] |
Giralt, Sergio |
- Blood and Marrow Transplantation
- Hematology
- Multiple Myeloma
- Myelodysplastic Syndrome
- Leukemia
- Acute Lymphoblastic Leukemia
- Acute Myelocytic Leukemia
- Acute Myelogenous Leukemia
- Chronic Lymphocytic Leukemia
- Chronic Myelocytic Leukemia
- Myelodysplastic Syndrome
- Lymphoma
- Hodgkin's Disease
- Non-Hodgkin's Lymphoma
|
A Phase II Study of Cixutumumab plus Temsirolimus in Children with Recurrent or Refractory Sarcoma
[Protocol 12-188] |
Wexler, Leonard |
- Primary Bone
- Sarcomas
- Osteosarcoma
- Soft Tissue Sarcoma
|
A Phase II Study of CMV-Immune T cells for the Treatment of Cytomegalovirus Infection after Stem Cell Transplantation
[Protocol 12-086] |
O'Reilly, Richard |
- Blood & Marrow Stem Cell Transplantation
|
A Phase II Study of Cyclophosphamide, Topotecan, and Bevacizumab in Patients with Relapsed or Refractory Ewing's Sarcoma and Neuroblastoma
[Protocol 11-183] |
Trippett, Tanya |
- Neuroblastoma
- Primary Bone
- Sarcomas
- Ewing's Sarcoma
- Soft Tissue Sarcoma
|
A Phase II Study of Dasatinib in Children and Adolescents Newly Diagnosed with Chronic Phase CML or with Philadelphia Chromosome-Positive Leukemias Resistant to or Intolerant of Imatinib
[Protocol 11-030] |
Shukla, Neerav |
- Leukemia
- Acute Lymphoblastic Leukemia
- Chronic Myelocytic Leukemia
|
A Phase II Study of Everolimus, Leuprolide/Letrozole, and Everolimus/Leuprolide/Letrozole in Patients with Inoperable Fibrolamellar Hepatocellular Carcinoma
[Protocol 11-211] |
Abou-Alfa, Ghassan |
|
A Phase II Study of High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of First Remission after Non-Myeloablative Therapy in Patients with High-Risk Neuroblastoma
[Protocol 09-159] |
Kushner, Brian |
|
A Phase II Study of High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Consolidation of Second or Greater Remission of High-Risk Neuroblastoma
[Protocol 09-160] |
Kushner, Brian |
|
A Phase II Study of High-Dose 3F8/GM-CSF Immunotherapy Plus 13-Cis-Retinoic Acid for Primary Refractory Neuroblastoma in the Bone Marrow
[Protocol 09-161] |
Kushner, Brian |
|
A Phase II Study of Inhaled Lipid Cisplatin in Pulmonary Recurrent Osteosarcoma
[Protocol 12-205] |
Chou, Alexander |
|
